Phd Steven Gullans - President & CEO, Gemphire Therapeutics Inc

As of July 26, 2019


Phd Steven Gullans Net Worth

  • Net worth is estimated to be at least $1.05M
  • Owns at least 930,252 units of Gemphire Therapeutics Inc stock

Phd Steven Gullans Trading

  • Largest purchase of shares was 806,025 units , worth over $7.05M on August 12, 2016
  • In total has made about 9 transactions over 3 years
  • Usually trades in May, with the busiest year in 2018
Ticker
Type
Value
Price per Share
Shares
Filing Date
No matching records found
1

Phd Steven Gullans Mailing Address

  • Mailing address is C/o Excel Venture Management, Llc 800 Boylston St., Ste 2825 Boston MA 02199 MA

Gemphire Therapeutics Inc Insider Trading

  • The most recent transaction was 14,286 units bought on February 12, 2018 by Seth Reno worth over $100K
  • In the last 2 years, insiders at Gemphire Therapeutics Inc bought an estimated value of $12.36M
  • The most active traders are Phd Steven Gullans, President & CEO,  Andy Sassine, Director,  and Jeffrey Mathiesen, Chief Financial Officer
  • Insider trading is most common in August, with the busiest year in 2016

Gemphire Therapeutics Inc. Insider Trades

Insider Names
Type
Value
Price per Share
Shares
Filing Date
No matching records found
1